 |
|
Anticardiolipin Antibodies Are Frequently Present in Patients With Idiopathic Intracranial Hypertension
Ronen R. Leker, MD;
Israel Steiner, MD
Arch Neurol. 1998;55:817-820.
Background Anticardiolipin antibodies (ACL-Ab) are associated with various neurologic syndromes, but idiopathic intracranial hypertension (IIH) has only rarely been reported in this context.
Objectives To delineate the frequency and clinical and radiological features of, as well as the cause-and-effect relationship between, ACL-Ab and IIH.
Methods We analyzed the medical records of patients with IIH hospitalized between January 1989 and September 1995. All patients underwent magnetic resonance imaging or magnetic resonance venography or angiography. Excluded were patients with intracranial hypertension due to dural sinus thrombosis or traumatic, structural, neoplastic, or infectious disorders. Patients who were found on at least 2 separate occasions to have increased IgG titers of ACL-Ab were identified and compared with patients without ACL-Ab.
Results Six (43%) of 14 patients with IIH had ACL-Ab. No differences in clinical, laboratory, or radiological variables could be found between patients with and without ACL-Ab. Only 3 of the 11 ACL-Ab–positive patients had previous systemic or neurologic abnormalities associated with ACL-Ab.
Conclusions Anticardiolipin antibodies may cause IIH through mechanisms unrelated to major venous thrombosis. Idiopathic intracranial hypertension is frequently associated with ACL-Ab and can be the presenting symptom of the antiphospholipid syndrome. There are no major clinical, laboratory, or radiological features that distinguish between patients with IIH with and without ACL-Ab.
From the Department of Neurology, Hebrew University, Hadassah University Medical Center, Jerusalem, Israel.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Central nervous system involvement in the antiphospholipid (Hughes) syndrome
Sanna et al.
Rheumatology (Oxford) 2003;42:200-213.
ABSTRACT
| FULL TEXT
Anticardiolipin antibodies in patients with multiple sclerosis do not represent a subgroup of patients according to clinical, familial, and biological characteristics
Heinzlef et al.
J. Neurol. Neurosurg. Psychiatry 2002;72:647-649.
ABSTRACT
| FULL TEXT
Idiopathic intracranial hypertension: any light on the mechanism of the raised pressure?
WALKER
J. Neurol. Neurosurg. Psychiatry 2001;71:1-5.
FULL TEXT
Idiopathic intracranial hypertension and anticardiolipin antibodies
Kesler et al.
J. Neurol. Neurosurg. Psychiatry 2000;68:379-380.
ABSTRACT
| FULL TEXT
Anticardiolipin Antibodies
Howell et al.
Arch Neurol 1999;56:760-760.
FULL TEXT
|
